Lawrence T. Kennedy Jr - Apr 5, 2024 Form 4 Insider Report for BIODESIX INC (BDSX)

Signature
/s/ Robin H. Cowie as Attorney-in-Fact for Lawrence T. Kennedy, Jr.
Stock symbol
BDSX
Transactions as of
Apr 5, 2024
Transactions value $
$5,000,016
Form type
4
Date filed
4/9/2024, 07:32 PM
Previous filing
Jan 3, 2024
Next filing
May 23, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSX Series A Non-Voting Convertible Preferred Stock Award $2M +43.5K $46.00* 43.5K Apr 5, 2024 Common Stock 1.74M By: Lawrence T. Kennedy, Jr. Perpetuity Trust UAD 6/30/16 F1
transaction BDSX Series A Non-Voting Convertible Preferred Stock Award $3M +65.2K $46.00* 65.2K Apr 5, 2024 Common Stock 2.61M By: KFDI-B LLC F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer has agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its 2024 annual meeting of stockholders (the "Conversion Proposal"). Following such approval of the Conversion Proposal, each share of Preferred Stock will automatically convert into 40 shares of Common Stock, subject to certain limitations, including that the Reporting Person is prohibited from converting shares of Preferred Stock into shares of Common Stock if, as a result of such conversion, the Reporting Person, together with his affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. The Preferred Stock has no expiration date.